Originally published at: Procter & Gamble to Acquire Thorne for $3.8 Billion: Will the...
P&G is buying Thorne for $3.8 billion, roughly 7.6x annual revenue. The manufacturing and NSF certifications probably stay put. The clinical research budget is the real question, and P&G’s history with New Chapter isn’t reassuring. Thorne is being acquired by Procter & Gamble in a deal reportedly worth $3.8 billion,… ..(Read more on the PricePlow Blog)